Clinical Trials Directory

Trials / Conditions / Immunocompromised Host

Immunocompromised Host

7 registered clinical trials studyying Immunocompromised Host — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCOVID-19 Booster and IIV Schedule in Immunocompromised Hosts
NCT06599658
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 2
CompletedPre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authori
NCT05216588
ANRS, Emerging Infectious Diseases—
CompletedICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients
NCT04043793
University Hospital, Lille—
CompletedPneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
NCT04047719
Karius, Inc.—
CompletedOxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients
NCT02424773
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedEarly Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonar
NCT00923832
National Cancer Institute (NCI)—
CompletedCancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
NCT00904579
National Cancer Institute (NCI)—